AeroLeads people directory · profile

Greg Oehrtman, Ph.D. Email & Phone Number

VP of TechOps at Aveo Oncology at AVEO Oncology
Location: Greater Boston, United States, United States 9 work roles 3 schools
1 work email found @aveooncology.com 3 phones found area 617 LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 3 phones

Work email g****@aveooncology.com
Direct phone (617) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
VP of TechOps at Aveo Oncology
Location
Greater Boston, United States, United States

Who is Greg Oehrtman, Ph.D.? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Greg Oehrtman, Ph.D. is listed as VP of TechOps at Aveo Oncology at AVEO Oncology, based in Greater Boston, United States, United States. AeroLeads shows a work email signal at aveooncology.com, phone signal with area code 617, and a matched LinkedIn profile for Greg Oehrtman, Ph.D..

Greg Oehrtman, Ph.D. previously worked as VP of Technical Operations at Aveo Oncology and TechOps, CMC, Supply Chain and Formulation/Device Development Expert at Oehrtman Consulting, Llc. Greg Oehrtman, Ph.D. holds Ph.D., Chemical Engineering from Massachusetts Institute Of Technology.

Company email context

Email format at AVEO Oncology

This section adds company-level context without repeating Greg Oehrtman, Ph.D.'s masked contact details.

*@aveooncology.com
68% confidence

AeroLeads found 1 current-domain work email signal for Greg Oehrtman, Ph.D.. Compare company email patterns before reaching out.

Profile bio

About Greg Oehrtman, Ph.D.

Experienced leader of TechOps, CMC, formulation development, clinical/commercial supply logistics, and injection device departments in small and large molecule formulation, scale-up process development and clinical/commercial product. Dosage forms developed and manufactured for clinical studies and validation/commercial launch include oral solids, sterile liquids / parenterals and topicals.Specialties: Small Molecule Formulation Development - IR and SRLarge Molecule Formulation Development - IR and SRTablet, Capsule, softgel, Injectable/parenteral dosage forms Fluid Bed, Pan Coating (film & enteric), controlled release, granulation, improve API solubilityRegulatory CMC sections - IND, NDA and IMPDLeading Cross Discipline Project TeamsProject ManagementBusiness Planning - Budgets, Timelines, proposalsCommercial Product Launch planning for combination productCommercial and Clinical labeling/packaging/distribution for global logistics supply chain.Controlled-release microspheres, Protein, Peptides, lyophilization, sustain-release, immediate release, polymer, granulation, fluid bed drying / coating, film coating, batch records, CRO, CMO, contract research organization, pharmaceutical development, PLGA, PFS, pre-filled syringe, cartridges, aseptic fill finish, analytical, TechOps, CMC, Technical Operations, BioTech, auto-injector, reusable injection pen, DHF, device

Listed skills include Formulation, Gmp, Pharmaceutical Industry, Biotechnology, and 43 others.

Current workplace

Greg Oehrtman, Ph.D.'s current company

Company context helps verify the profile and gives searchers a useful next step.

AVEO Oncology
Aveo Oncology
VP of TechOps at Aveo Oncology
Website
AeroLeads page
9 roles

Greg Oehrtman, Ph.D. work experience

A career timeline built from the work history available for this profile.

Vp Of Technical Operations

Current

Boston, Massachusetts, US

Leading Drug Substance and Drug Product Development and Manufacturing of small molecule and antibodies for phase 1 thru commercial.Leading Multi-functional team including Clinical Supplies, Commercial Supplies and Analytical Development for Fotivda commercial capsules and parenteral IV antibodies.

Aug 2022 - Present

Techops, Cmc, Supply Chain And Formulation/Device Development Expert

Current
Oehrtman Consulting, Llc

CMC expert in Formulation Development & Manufacturing (small and large molecule in oral and injectable dosages), Clinical Supply Chain, Class II Device, and CMC regulatory submissions.

Feb 2020 - Present

Executive Director, Ds & Dp Manufacturing And Device,

Lexington, Massachusetts, US

Led Development/Manufacturing Team responsible for clinical and commercial Drug Substance (Oligonucleotide), Drug Product (parenteral injection), Injection Device Development, and Regulatory Writing across multiple internal and partnership programs.

Jun 2020 - Aug 2022

Executive Director, Formulations, Manufacturing, Supply Chain, Device Development, Commercial Launch

Needham, Massachusetts, US

Led the development and execution of program strategies with multi-functional teams, planning drug product, clinical and commercial packaging/labeling/distribution and device strategies for clinical studies and commercial launch product.Developed reusable injection pen for clinical Phase 3 study and scale-up for commercialization with human factor studies.

Aug 2018 - Jan 2020

Sr. Director, Cmc & Techops

Needham, Massachusetts, US

Oversee development and execution of program strategies with multi-functional teams, planning drug product, clinical packaging/labeling/distribution and device strategies for clinical studies and commercial launch product.Evaluate and recommend device platforms for injectable products (auto-injector, multi-use pen, infusion pumps), company proceeding with.

Sep 2014 - Aug 2018

Director, Product Development

Boston, Massachusetts, US

Led formulation development, clinical manufacturing, and process development of sterile monoclonal antibody injectable for oncology drug products at contract manufacturers. Led Registration Manufacturing campaign, Process Validation manufacturing, transfer of clinical/commercial manufacturing to new CMO, and double-blind and open label clinical.

Apr 2011 - Sep 2014

Assoc. Director, Formulation Development Parenterals

San Diego, CA, US

  • Led Parenteral Formulation Department, successful in developing new technologies and solving process challenges; department frequently requested to solve challenges. Staff included up to 18 people consisting of.
  • Managed formulation development of parenteral dosages and clinical supply.
  • Injectable pens, large molecule solutions, lyophilization, controlled-release microspheres, polymer diluent solution.
  • Solved technological challenges of ready-to-use non-aqueous delivery of PLGA microspheres, manufacturing challenges of heat labile polymer, and API gelling.
  • Contributed to IND and NDA CMC Regulatory section for injectable compounds.CMC Team Leader of weight loss compound, davalintide.
  • Collaborated with external technology partner to build GMP processing train at partner site, scaled up a unique/novel formulation, and manufactured clinical supplies
Jan 2007 - Aug 2010

Senior Manager, Formulation Development Oral Solids

Durham, North Carolina, US

  • Managed a Solids formulation group of 8 employees, including: Ph.D. Scientist, Formulators (3) and Technicians (4).
  • 50%+ work received from repeat clients; worked closely with clientele on project planning scope, budgeting, and technical execution of their programs.
  • Developed business proposals, budgeting forecasting, set project timelines, and authored product development history reports and CMC regulatory sections for IND.
  • Performed departmental recruiting, hired approximately 50% of Solids department.
  • Coordinated formulation, analytical, dissolution, clinical, regulatory, and packaging assignments to meet customer timelines and expectations.
  • Formulation development of sustain-release, immediate release, and semi-solid dosage forms, developing innovative, patentable solutions overcoming formulation challenges.
Apr 2000 - Dec 2006

Scientist, Formulation Development Oral Solids

New York, New York, US

  • Formulation development of conventional solid dosage forms and coating technologies.
  • Coordinated and monitored projects for the following dosage forms: Softgels, gelatin coated tablets, film coated tablets and capsules, chewable tablets.
  • Authored and monitored stability programs for developmental, clinical, and commercial formulations using LIMS system with stability/expiry dating reports.
  • Performed NDA production batch scale-up from research formulation and development.
  • Sub-Team Leader for Analgesics Product Development – Advil PM formulation to NDA stability.
  • Pharmaceutical Research and Development RepresentativeManaged Product Submission and Support Activities Team – Interfaced R&D with Marketing, Regulatory, Clinical to support Advil clinical trials.Clinical Supplies.
Mar 1998 - Mar 2000
Team & coworkers

Colleagues at AVEO Oncology

Other employees you can reach at eusapharma.com. View company contacts →

3 education records

Greg Oehrtman, Ph.D. education

Ph.D., Chemical Engineering

Massachusetts Institute Of Technology

Ms, Chemical Engineering

University Of Illinois Urbana-Champaign

Bs, Chemical Engineering

The University Of Texas At Austin
FAQ

Frequently asked questions about Greg Oehrtman, Ph.D.

Quick answers generated from the profile data available on this page.

What company does Greg Oehrtman, Ph.D. work for?

Greg Oehrtman, Ph.D. works for AVEO Oncology.

What is Greg Oehrtman, Ph.D.'s role at AVEO Oncology?

Greg Oehrtman, Ph.D. is listed as VP of TechOps at Aveo Oncology at AVEO Oncology.

What is Greg Oehrtman, Ph.D.'s email address?

AeroLeads has found 1 work email signal at @aveooncology.com for Greg Oehrtman, Ph.D. at AVEO Oncology.

What is Greg Oehrtman, Ph.D.'s phone number?

AeroLeads has found 3 phone signal(s) with area code 617 for Greg Oehrtman, Ph.D. at AVEO Oncology.

Where is Greg Oehrtman, Ph.D. based?

Greg Oehrtman, Ph.D. is based in Greater Boston, United States, United States while working with AVEO Oncology.

What companies has Greg Oehrtman, Ph.D. worked for?

Greg Oehrtman, Ph.D. has worked for Aveo Oncology, Oehrtman Consulting, Llc, Dicerna Pharmaceuticals, Inc., Stealth Biotherapeutics, and Aveo Pharmaceuticals.

Who are Greg Oehrtman, Ph.D.'s colleagues at AVEO Oncology?

Greg Oehrtman, Ph.D.'s colleagues at AVEO Oncology include Manuel Silva, Manisha Morgan, Beth Duffy, Thao Tang, and Derek Glover.

How can I contact Greg Oehrtman, Ph.D.?

You can use AeroLeads to view verified contact signals for Greg Oehrtman, Ph.D. at AVEO Oncology, including work email, phone, and LinkedIn data when available.

What schools did Greg Oehrtman, Ph.D. attend?

Greg Oehrtman, Ph.D. holds Ph.D., Chemical Engineering from Massachusetts Institute Of Technology.

What skills is Greg Oehrtman, Ph.D. known for?

Greg Oehrtman, Ph.D. is listed with skills including Formulation, Gmp, Pharmaceutical Industry, Biotechnology, Drug Development, Ind, Chemistry, and Fda.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.